Allianz Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $690M | Buy |
|
|||||
|
2025
Q1 | $648M | Buy |
|
|||||
|
2024
Q4 | $472M | Buy |
|
|||||
|
2024
Q3 | $363M | Buy |
|
|||||
|
2024
Q2 | $289M | Sell |
|
|||||
|
2024
Q1 | $316M | Buy |
|
|||||
|
2023
Q4 | $342M | Buy |
|
|||||
|
2023
Q3 | $298M | Buy |
|
|||||
|
2023
Q2 | $288M | Buy |
|
|||||
|
2023
Q1 | $263M | Buy |
|
|||||
|
2022
Q4 | $261M | Sell |
|
|||||
|
2022
Q3 | $227M | Sell |
|
|||||
|
2022
Q2 | $246M | Sell |
|
|||||
|
2022
Q1 | $240M | Sell |
|
|||||
|
2021
Q4 | $304M | Sell |
|
|||||
|
2021
Q3 | $306M | Buy |
|
|||||
|
2021
Q2 | $78.7M | Sell |
|
|||||
|
2021
Q1 | $94M | Buy |
|
|||||
|
2020
Q4 | $76.4M | Buy |
|
|||||
|
2020
Q3 | $68.8M | Sell |
|
|||||
|
2020
Q2 | $201M | Sell |
|
|||||
|
2020
Q1 | $258M | Sell |
|
|||||
|
2019
Q4 | $237M | Sell |
|
|||||
|
2019
Q3 | $234M | Sell |
|
|||||
|
2019
Q2 | $295M | Sell |
|
|||||
|
2019
Q1 | $297M | Sell |
|
|||||
|
2018
Q4 | $299M | Buy |
|
|||||
|
2018
Q3 | $350M | Buy |
|
|||||
|
2018
Q2 | $278M | Sell |
|
|||||
|
2018
Q1 | $330M | Sell |
|
|||||
|
2017
Q4 | $366M | Buy |
|
|||||
|
2017
Q3 | $366M | Buy |
|
|||||
|
2017
Q2 | $287M | Buy |
|
|||||
|
2017
Q1 | $246M | Sell |
|
|||||
|
2016
Q4 | $335M | Buy |
|
|||||
|
2016
Q3 | $342M | Sell |
|
|||||
|
2016
Q2 | $595M | Buy |
|
|||||
|
2016
Q1 | $631M | Buy |
|
|||||
|
2015
Q4 | $681M | Buy |
|
|||||
|
2015
Q3 | $635M | Buy |
|
|||||
|
2015
Q2 | $731M | Buy |
|
|||||
|
2015
Q1 | $369M | Sell |
|
|||||
|
2014
Q4 | $429M | Sell |
|
|||||
|
2014
Q3 | $526M | Sell |
|
|||||
|
2014
Q2 | $414M | Sell |
|
|||||
|
2014
Q1 | $372M | Buy |
|
|||||
|
2013
Q4 | $373M | Buy |
|
|||||
|
2013
Q3 | $267M | Buy |
|
|||||
|
2013
Q2 | $165M | Buy |
|